Literature DB >> 12116254

Complete SHOX deficiency causes Langer mesomelic dysplasia.

Andrew R Zinn1, Fanglin Wei, Ling Zhang, Frederick F Elder, Charles I Scott, Pia Marttila, Judith L Ross.   

Abstract

The SHOX (short-stature homeobox-containing) gene encodes isoforms of a homeodomain transcription factor important in human limb development. SHOX haploinsufficiency has been implicated in three human growth disorders: Turner syndrome, idiopathic short stature, and Leri-Weill dyschondrosteosis. Langer mesomelic dysplasia is thought to be the homozygous form of dyschondrosteosis. However, complete SHOX deficiency has not been demonstrated for any postnatal patient with the classic Langer phenotype. We studied four adults and one child with Langer mesomelic dysplasia. SHOX abnormalities were detected in all five probands. One was a homozygote or hemizygote and two were compound heterozygotes. The homozygous or hemizygous mutation was in exon 6a, implying that the SHOXa isoform is essential for normal skeletal development. These findings confirm clinical inferences that Langer mesomelic dysplasia is the homozygous form of Leri-Weill dyschondrosteosis and add to our understanding of genotype/phenotype relationships in SHOX deficiency disorders. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12116254     DOI: 10.1002/ajmg.10422

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  33 in total

1.  Identification of the first PAR1 deletion encompassing upstream SHOX enhancers in a family with idiopathic short stature.

Authors:  Sara Benito-Sanz; Miriam Aza-Carmona; Amaya Rodríguez-Estevez; Ixaso Rica-Etxebarria; Ricardo Gracia; Angel Campos-Barros; Karen E Heath
Journal:  Eur J Hum Genet       Date:  2011-11-09       Impact factor: 4.246

Review 2.  Genetic disorders of the skeleton: a developmental approach.

Authors:  Uwe Kornak; Stefan Mundlos
Journal:  Am J Hum Genet       Date:  2003-07-31       Impact factor: 11.025

3.  The role of Shox2 in SAN development and function.

Authors:  Hongbing Liu; Ramón A Espinoza-Lewis; Chaohui Chen; Xuefeng Hu; Yanding Zhang; Yiping Chen
Journal:  Pediatr Cardiol       Date:  2012-02-04       Impact factor: 1.655

4.  A mouse model for human short-stature syndromes identifies Shox2 as an upstream regulator of Runx2 during long-bone development.

Authors:  John Cobb; Andrée Dierich; Yolande Huss-Garcia; Denis Duboule
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-13       Impact factor: 11.205

5.  Y chromosome gene copy number and lack of autism phenotype in a male with an isodicentric Y chromosome and absent NLGN4Y expression.

Authors:  Judith L Ross; Luke Bloy; Timothy P L Roberts; Judith Miller; Chao Xing; Lawrence A Silverman; Andrew R Zinn
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2019-06-03       Impact factor: 3.568

6.  Choline kinase beta is required for normal endochondral bone formation.

Authors:  Zhuo Li; Gengshu Wu; Roger B Sher; Zohreh Khavandgar; Martin Hermansson; Gregory A Cox; Michael R Doschak; Monzur Murshed; Frank Beier; Dennis E Vance
Journal:  Biochim Biophys Acta       Date:  2014-03-14

7.  A Leri-Weill dyschondrosteosis patient confirmed by mutation analysis of SHOX gene.

Authors:  Won Bok Choi; Seung Hyeon Seo; Woo Hyun Yoo; Su Young Kim; Min Jung Kwak
Journal:  Ann Pediatr Endocrinol Metab       Date:  2015-09-30

8.  The Human Pseudoautosomal Region (PAR): Origin, Function and Future.

Authors:  A Helena Mangs; Brian J Morris
Journal:  Curr Genomics       Date:  2007-04       Impact factor: 2.236

9.  A novel intronic mutation in SHOX causes short stature by disrupting a splice acceptor site: direct demonstration of aberrant splicing by expression of a minigene in HEK-293T cells.

Authors:  Jennifer Danzig; Michael A Levine
Journal:  J Pediatr Endocrinol Metab       Date:  2012       Impact factor: 1.634

Review 10.  SHOX Haploinsufficiency as a Cause of Syndromic and Nonsyndromic Short Stature.

Authors:  Maki Fukami; Atsuhito Seki; Tsutomu Ogata
Journal:  Mol Syndromol       Date:  2016-03-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.